HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): David P. Taggart Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taggart, D. P. Search for Related Content PubMed PubMed Citation Articles by Taggart, D. P.

J Thorac Cardiovasc Surg 2000;120:651-659
© 2000 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

Biochemical assessment of myocardial injury after cardiac surgery: Effects of a platelet activating factor antagonist, bilateral internal thoracic artery grafts, and coronary endarterectomy

From Oxford Heart Centre, John Radcliffe Hospital, Oxford, United Kingdom.

Funded by British Biotech Pharmaceuticals Ltd, Watlington Rd, Oxford, OX4 5LY, United Kingdom.

Address for reprints: D. P. Taggart, MD, FRCS, Consultant Cardiothoracic Surgeon, Oxford Heart Centre, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom (E-mail: david.taggart{at}orh.anglox.nhs.uk).

Objective: Platelet activating factor antagonists reduce ischemia-reperfusion injury in experiments, but there is no supportive clinical evidence.
Methods: A single-center, double-blind, minimized, placebo-controlled, randomized trial of low-dose (10 mg) or high-dose (100 mg) platelet activating factor antagonist was conducted in 150 patients undergoing coronary artery bypass grafting. Myocardial injury was determined by serial measurements of the MB isoenzyme of creatine kinase and cardiac troponin T. The effects of single or bilateral internal thoracic artery grafting and coronary endarterectomy on myocardial injury were also assessed.
Results: The placebo and platelet activating factor antagonist groups were similar with respect to preoperative, intraoperative, and postoperative factors. Four patients (2.7%) died before discharge, 3 from cardiac events. Thirteen patients (9%) had biochemical evidence of myocardial infarction, of whom 3 died. Stepwise multiple regression analysis demonstrated that duration of cardiopulmonary bypass was the most important determinant of elevations in creatine kinase MB isoenzyme and cardiac troponin T up to 6 hours after the operation and that the use of a platelet activating factor antagonist and the number of internal thoracic artery grafts did not influence myocardial injury at any time. Endarterectomy was performed in 11 patients (7%), of whom 6 (55%) had biochemically defined myocardial infarction and of whom 1 died (9%). Endarterectomy was the most important determinant of elevated levels of creatine kinase MB isoenzyme and cardiac troponin T 24 and 48 hours after the operation.
Conclusion: Platelet activating factor antagonists do not reduce perioperative myocardial injury. Bilateral and single internal thoracic artery grafting results in similar levels of myocardial injury, whereas endarterectomy is frequently associated with biochemical evidence of myocardial injury.

This article has been cited by other articles:

				L. Balacumaraswami and D. P. Taggart Intraoperative Imaging Techniques to Assess Coronary Artery Bypass Graft Patency Ann. Thorac. Surg., June 1, 2007; 83(6): 2251 - 2257. [Abstract] [Full Text] [PDF]

				H. A. Vohra, R. Kanwar, T. Khan, and W. R. Dimitri Early and late outcome after off-pump coronary artery bypass graft surgery with coronary endarterectomy: a single-center 10-year experience. Ann. Thorac. Surg., May 1, 2006; 81(5): 1691 - 1696. [Abstract] [Full Text] [PDF]

				D. C Whitaker, J. Stygall, M. J. Harrison, I. J Mackie, M. Kemp, J. Hooper, W. B Pugsley, and S. P Newman Leucocyte-depleting arterial line filtration does not reduce myocardial injury assessed by Troponin T during routine coronary artery bypass grafting using crossclamp fibrillation Perfusion, January 1, 2006; 21(1): 55 - 60. [Abstract] [PDF]

				L. Balacumaraswami, Y. Abu-Omar, B. Choudhary, D. Pigott, and D. P. Taggart A comparison of transit-time flowmetry and intraoperative fluorescence imaging for assessing coronary artery bypass graft patency J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 315 - 320. [Abstract] [Full Text] [PDF]

				R. Pandey, A. D. Grayson, D. M. Pullan, B. M. Fabri, and W. C. Dihmis Total arterial revascularisation: effect of avoiding cardiopulmonary bypass on in-hospital mortality and morbidity in a propensity-matched cohort Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 94 - 98. [Abstract] [Full Text] [PDF]

				J. B. Selvanayagam, S. Neubauer, and D. P. Taggart Quantification of peri-operative myocardial infarction after coronary artery bypass surgery Eur. Heart J., December 1, 2004; 25(23): 2171 - 2171. [Full Text] [PDF]

				J. G. Byrne, A. N. Karavas, T. Gudbjartson, M. Leacche, J. D. Rawn, G. S. Couper, R. J. Rizzo, L. H. Cohn, and S. F. Aranki Left anterior descending coronary endarterectomy: Early and late results in 196 consecutive patients Ann. Thorac. Surg., September 1, 2004; 78(3): 867 - 873. [Abstract] [Full Text] [PDF]

				C. Chen-Scarabelli, T. M. Scarabelli, J. B. Selvanayagam, S. E. Petersen, J. M. Francis, M. D. Robson, A. Kardos, S. Neubauer, and D. P. Taggart Myocardial Injury and Cardiac Troponin I Release After Off-Pump Versus On-Pump Coronary Surgery * Response Circulation, July 27, 2004; 110(4): e36 - e36. [Full Text] [PDF]

				J. B. Selvanayagam, S. E. Petersen, J. M. Francis, M. D. Robson, A. Kardos, S. Neubauer, and D. P. Taggart Effects of Off-Pump Versus On-Pump Coronary Surgery on Reversible and Irreversible Myocardial Injury: A Randomized Trial Using Cardiovascular Magnetic Resonance Imaging and Biochemical Markers Circulation, January 27, 2004; 109(3): 345 - 350. [Abstract] [Full Text] [PDF]

				D. P. Taggart, B. Choudhary, K. Anastasiadis, Y. Abu-Omar, L. Balacumaraswami, and D. W. Pigott Preliminary experience with a novel intraoperative fluorescence imaging technique to evaluate the patency of bypass grafts in total arterial revascularization Ann. Thorac. Surg., March 1, 2003; 75(3): 870 - 873. [Abstract] [Full Text] [PDF]

				M J Naik, Y Abu-Omar, A Alvi, N Wright, A Henderson, K Channon, J C Forfar, and D P Taggart Total arterial revascularisation as a primary strategy for coronary artery bypass grafting Postgrad. Med. J., January 1, 2003; 79(927): 43 - 48. [Abstract] [Full Text] [PDF]

				D. P. Taggart, S. Neubauer, M. A. Costa, D. P. Foley, P. W. Serruys, R. G. Carere, S. V. Lichtenstein, V. de Valk, W. Lindenboom, P. C.H. Roose, et al. Incidence, Predictors, and Significance of Abnormal Cardiac Enzyme Rise in Patients Treated With Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS) * Response Circulation, September 24, 2002; 106 (13): e55 - e56. [Full Text] [PDF]

				D P Taggart Bilateral internal mammary artery grafting: are BIMA better? Heart, July 1, 2002; 88(1): 7 - 9. [Full Text] [PDF]

				P. J. Pugh, L. O'Toole, K. S. Channer, D. P. Taggart, A. Banning, K. Channon, M. J. Mack, M. Murtaza, M. Singh, L. Dharmarajan, et al. Coronary-Artery Bypass Surgery versus Stenting for Multivessel Disease N. Engl. J. Med., November 29, 2001; 345(22): 1641 - 1643. [Full Text] [PDF]